Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-07

FDA Approved: ELETRIPTAN HYDROBROMIDE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' Eletriptan Hydrobromide as an original generic application for the acute treatment of migraine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eletriptan Hydrobromide (eletriptan hydrobromide)

Snippet

ORIG AP for ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE)